SPP1 and chronic kidney disease: A cohort study that analyzed the effect of SPP1 polymorphisms in CVE in patients with chronic kidney disease found that the group of patients with cardiovascular events (CVE) had a higher incidence of atherosclerotic plaque and higher OPN levels at baseline.